About PAB
Patrys Limited (PAB) is a clinical-stage biotech creating patient and shareholder value through rapid clinical advancement of IV quetiapine for delirium and early development of Deoxymabs, an antibody platform targeting inflammatory diseases.
Find out what a historical investment in Patrys would be worth today using our PAB stock calculator.
Market Capitalisation
$20.25M
Price-earnings ratio
-3.61
Dividend yield
-
High today
$0.03
Low today
$0.03
Open price
$0.03
52-week high
$0.05
52-week low
$0.02
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PAB
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in PAB on Stake
- Buy PAB from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
PAB related stocks